Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Explore the latest updates presented at major international congresses in the form of video interviews, podcasts and roundtable discussions featuring members of our expert Editorial Board.
Exciting advances are being made in the field of genitourinary cancer, including checkpoint inhibitor treatments, new non-steroidal anti-androgens, chemoimmunotherapy combinations and predictive biomarkers.
GU cancer experts highlight key updates in bladder, kidney, and prostate cancers at ASCO GU 2025.
Including insights on the latest in novel treatments, combinations and long-term outcomes in RCC and bladder cancer; and investigating outcomes, evolving therapeutics and biomarkers in prostate cancer.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.